Clinical Trials Directory

Trials / Unknown

UnknownNCT02202460

The Potential Biomark of Serious Psychosis:a Prospective,Case-controled Study

The Potential Biomark of Serious Psychosis: Including the Variation of Brain MRI, BDNF and Oxidative Stress-related Immunological Factors in Different Phases.

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Central South University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Patients suffer from Serious Psychosis may have variation in immunological factors,BDNF and MRI.

Detailed description

Patients suffer from Schizophrenia and Mood Disorders may have variation in immunological factors(TNF-α,IL-2,IL-6,IL-10,etc),BDNF and Brain MRI.

Conditions

Timeline

Start date
2014-08-01
Primary completion
2016-12-01
Completion
2020-12-01
First posted
2014-07-29
Last updated
2014-07-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02202460. Inclusion in this directory is not an endorsement.

The Potential Biomark of Serious Psychosis:a Prospective,Case-controled Study (NCT02202460) · Clinical Trials Directory